Breast Cancer Clinical Trial

Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study

Summary

Metastatic breast cancer (MBC) is an incurable disease. Maintaining optimum quality of life is a major goal of care. There is a strong body of evidence that exercise can reduce or manage fatigue, depression and insomnia in breast cancer patients; however, the evidence base is overwhelmingly in early stage cancer patients. The purpose of this study is to see if a home-based, self-directed walking program can have similar benefits in women with an MBC diagnosis. The primary objective is to evaluate whether engagement in physical activity will reduce fatigue during active treatment for MBC (baseline to 3 months); this is the primary endpoint. Secondary objectives pertain to feasibility of recruitment and retention of study participants and measuring changes between baseline, 3 months and 6 months in additional quality of life measures. Exploratory analyses pertain to changes in p16INK4a levels and sarcopenia between baseline and 3 months. The design is a single arm intervention trial in 30 patients. Findings from this study will provide preliminary data for a grant application to test the physical activity intervention in a randomized controlled trial (RCT) in a large sample of women with metastatic breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female
Age 21 or older
Metastatic breast cancer (MBC) diagnosis - Stage IV
Receiving treatment regimen for MBC, but no more than 3 previous chemotherapy or biologic regimens
Approval from the treating clinician to engage in moderate-intensity physical activity.
Patient-assessed ability to walk and engage in moderate physical activity
Proficient in English.
IRB approved signed written informed consent.
Willing and able to do all study requirements.

Exclusion Criteria:

One or more significant medical conditions or other issues that in the physician's judgment preclude participation in the walking intervention.
No more than 3 prior chemotherapy regimens.

Study is for people with:

Breast Cancer

Estimated Enrollment:

60

Study ID:

NCT02682836

Recruitment Status:

Completed

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

UNC Cancer Hospital
Chapel Hill North Carolina, 27519, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

60

Study ID:

NCT02682836

Recruitment Status:

Completed

Sponsor:


UNC Lineberger Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider